Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Insurance Companies Must Not Take Shortcuts with Medicare Advantage Record Keeping

Medicare Advantage has allegedly overcharged Medicare by $1,000 per policyholder. Melanie Musson, an insurance expert with ExpertInsuranceReviews.com, says, “Medicare Advantage insurance providers must prepare to justify their charges by keeping accurate records and documentation.” Medicare Advantage plans are increasing in popularity, but this private insurance alternative to government-run Original Medicare must be careful to be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Medicare Advantage has allegedly overcharged Medicare by $1,000 per policyholder. Melanie Musson, an insurance expert with ExpertInsuranceReviews.com, says, “Medicare Advantage insurance providers must prepare to justify their charges by keeping accurate records and documentation.”

Medicare Advantage plans are increasing in popularity, but this private insurance alternative to government-run Original Medicare must be careful to be transparent or keep accurate records, or they’ll pay the price.

Kaiser Health News recently reported on a trend of Medicare Advantage providers dodging auditors and overcharging taxpayers through billing Medicare.

Medicare Advantage Audit Failures Are Nothing New

In 2011, Blue Cross of Minnesota couldn’t locate records of podiatry patients who were treated at a podiatry clinic accepting Medicare. Federal audits revealed a combined care cost that exceeded $20,000. Due to circumstances surrounding that case and the podiatry clinic facing fraud allegations, the insurance provider was granted a hardship exemption.

But as demands for transparency increase, these exemptions may be harder to obtain, making it vitally important for Medicare Advantage providers to keep their own records and not depend on healthcare providers to give them documentation if needed for an audit.

The Cost of Medicare Advantage Failures

Medicare Advantage plans charge policyholders a premium, and they work with Medicare for payment for Medicare-covered services. Federal audits revealed that Medicare Advantage plans had overcharged Medicare for services averaging $1,000 per Medicare Advantage policyholder.

That equates to millions of dollars overcharged to Medicare. Those costs are passed down to taxpayers.

Medicare Advantage Should Prepare for More Oversight

The federal government has been working to demand repayment for overcharges from Medicare Advantage plan providers. So, these providers must prepare to back up all their charges with the proper documentation to avoid additional repayments or penalties.

Car insurance providers proved their commitment to fair compensation by issuing auto insurance givebacks in the midst of COVID-19 shutdowns. Medicare Advantage providers should take note and prepare to pay back the federal government if necessary.

Whether or not Medicare Advantage actually overcharged Medicare and, thereby, American Taxpayers is a moot point. With proper documentation and record-keeping, insurance providers can prove the legitimacy of their charges.

Medicare Advantage providers must resist the urge to save money by cutting corners and must instead keep organized records and follow the governmental red tape associated with the medicare program.

By doing so, insurance providers can protect themselves and regain the trust of their policyholders and the American taxpayers.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512